POLYPID LTD.
12Patents
12Active
12Granted
48Portfolio score
Filing activity: Jul 14, 2009 → Aug 11, 2022 · 3 expiring within 5 years
Most-cited patents
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US8992979B2 | Sustained-release drug carrier composition | Human Necessities | 6 | Active |
| US8877242B2 | Sustained-release drug carrier composition | Human Necessities | 2 | Active |
| US9421271B2 | Sustained-release drug carrier composition | Human Necessities | 2 | Active |
| US9616032B2 | Sustained-release nucleic acid matrix compositions | Human Necessities | 2 | Active |
| US9173976B2 | Compositions and methods for the treatment of bone voids and open fractures | Human Necessities | 2 | Active |
| US10682412B2 | Sustained-release drug carrier composition | Human Necessities | 2 | Active |
| US10105443B2 | Sustained-release drug carrier composition | Human Necessities | 1 | Active |
| US11471414B2 | Compositions and methods for the treatment and prophylaxis of surgical site infections | Human Necessities | 1 | Active |
| US10758639B2 | Methods for the treatment of peri-implantitis | Human Necessities | 0 | Active |
| US8795726B2 | Sustained-release nucleic acid matrix compositions | Human Necessities | 0 | Active |
| US10463617B2 | Sustained-release drug carrier composition | Human Necessities | 0 | Active |
| US11975101B2 | Compositions and methods for the treatment and prophylaxis of surgical site infections | Human Necessities | 0 | Active |
Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.